CLINICAL_TRIALS
trial_result
· 2014-07-03
Clinical Trial Update: Varenicline and Smoking Cessation in Schizophrenia [Phase 2]
Summary
Phase 2 trial evaluating varenicline for smoking cessation in individuals with schizophrenia. Results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Minnesota | Conditions: Schizophrenia, Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2014-07-03